Internal Medicine · Los Angeles, CA
NPI
1124119805
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1245 Wilshire Blvd Ste 785
Los Angeles, CA, 90017
Phone (213) 389-3200
Groups this clinician bills Medicare through
Medicare paid, 2024
$150K
3,576 services
Medicare patients, 2024
239
Average age 82
Drug cost, 2024
$2.5M
27,981 prescriptions
Company payments, 2025
$270
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jung M Bae was code 82962 (clinical chemistry), 647 times for 146 patients. In total Jung M Bae billed 3,576 services in 36 codes, and Medicare paid $150K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82962 Clinical Chemistry | Office | 647 | 146 | $3.21 | $2,077 |
| 99214 Office E&M - Established | Office | 529 | 194 | $101.55 | $54K |
| 36415 Venipuncture Blood Collection | Office | 485 | 227 | $8.65 | $4,195 |
| 99213 Office E&M - Established | Office | 377 | 128 | $70.36 | $27K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 282 | 56 | $0.73 | $207 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 181 | 181 | $151.72 | $27K |
| 96372 Injection Administration | Office | 173 | 72 | $11.55 | $1,999 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 159 | 70 | $0.30 | $48.03 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 146 | 146 | $22.81 | $3,331 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 141 | 141 | $22.82 | $3,218 |
| 81002 Clinical Chemistry | Office | 87 | 48 | $3.41 | $297 |
| G0008 Administration of influenza virus vaccine | Office | 64 | 64 | $29.40 | $1,882 |
| 90658 Vaccine Product | Office | 63 | 63 | $21.42 | $1,349 |
| 20610 Joint Injection | Office | 51 | 25 | $49.98 | $2,549 |
| 20550 Musculoskeletal | Office | 44 | 35 | $49.70 | $2,187 |
By year: 2022 $187K for 4,400 services; 2023 $154K for 3,723 services; 2024 $150K for 3,576 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 647 | 146 | $3.21 | $2,077 |
| 36415 Venipuncture Blood Collection | 485 | 227 | $8.65 | $4,195 |
| 81002 Clinical Chemistry | 87 | 48 | $3.41 | $297 |
Medicare prescription drug claims, 2024
In 2024, the drug Jung M Bae prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,442 prescriptions and refills. In total Jung M Bae wrote 27,981 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,442 | 2,857 | 284 | $5,782 |
| Pantoprazole Sodium Generic | 1,148 | 1,539 | 209 | $4,660 |
| Vascepa Icosapent Ethyl | 880 | 1,116 | 140 | $223K |
| Montelukast Sodium Generic | 782 | 1,047 | 125 | $2,683 |
| Losartan Potassium Generic | 699 | 1,305 | 139 | $2,678 |
| Amlodipine Besylate Generic | 676 | 1,162 | 122 | $1,340 |
| Levothyroxine Sodium Generic | 610 | 983 | 94 | $3,816 |
| Simvastatin Generic | 564 | 1,120 | 109 | $2,225 |
| Tamsulosin Hcl Generic | 546 | 927 | 100 | $2,853 |
| Memantine Hcl Er Memantine Hcl | 540 | 712 | 86 | $71K |
| Azithromycin Generic | 537 | 537 | 268 | $1,101 |
| Creon Lipase/Protease/Amylase | 466 | 522 | 116 | $364K |
| Metformin Hcl Er Metformin Hcl | 461 | 768 | 82 | $1,173 |
| Gabapentin Generic | 437 | 559 | 89 | $2,057 |
| Raloxifene Hcl Generic | 436 | 550 | 56 | $4,817 |
Brand drugs: 4,557 claims; generic drugs: 23,234 claims; opioid claims: 303.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jung M Bae $270 ($270 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.